莫努匹韦Molnupiravir治疗效果好不好？使用时应该注意什么

As an oral ribonucleoside analogue, Molnupiravir inhibits viral replication and reduces the viral load in patients by introducing errors in the viral replication process, thereby achieving the effect of treatment and blocking transmission. The administration method of twice a day for 5 consecutive days is more convenient and patients are more willing to accept it. Is the treatment effective? What should you pay attention to when using it?

Data from the Phase III MOVe-OUT study verified the therapeutic effect of the drug. First-time treatment patients were treated with Molnupiravir and placebo respectively. The hospitalization/death rate within 29 days was 7.3% in the monupivir treatment group and 14.1% in the placebo control group. The risk of hospitalization and death was reduced by 50% in the monupivir group, and no deaths were reported within 29 days, compared with eight deaths in the placebo control group. The results of this trial show that Molnupiravir can reduce the risk of hospitalization and death, improve the patient's disease progression and quality of life, and have a positive effect on the patient's condition.

Precautions for Molnupiravir

Patients with known severe hypersensitivity reactions to the active ingredient of Molnupiravir or any of its excipients should not be treated with this medicine. If a patient develops a severe allergic reaction during treatment with Molnupiravir, he or she should stop taking the medication immediately and go to the hospital for treatment. The doctor will diagnose the cause of the patient's allergy and prescribe medication. Patients who suffer from severe allergic reactions should permanently discontinue use of this medicine.

Treatment with Molnupiravir may cause harm to the fetus, so pregnant women should not use this drug for treatment. Patients should use effective contraception during treatment and for 4 days after the last dose of Molnupiravir.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: